Company: APXIF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026189
Chunk: 625

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1C
Chunk 625
---
AI or any Subsidiary of OmnigenicsAI to Parent or any shareholder
of Parent, shall be cancelled and extinguished. The Indebtedness described in this paragraph that is not required to be canceled and
extinguished at Closing shall have their maturity date extended to three years following the Closing Date.

47

On the Closing Date at the Merger Effective Time,
pursuant to the Business Combination Agreement, Merger Sub will merge with and into the Company (with the Company being the surviving
company and becoming a direct wholly-owned subsidiary of OmnigenicsAI) (the “Merger”) and, as a result of the Merger, (a)
each ordinary share of the Company (“SPAC Ordinary Share”) outstanding will be exchanged for the right to receive one ordinary
share of OmnigenicsAI, nominal value $0.0001 per share (“Company Share”), (b) all warrants to purchase SPAC Ordinary Shares
(“SPAC Warrants”) will become warrants of OmnigenicsAI (“Company Warrants”) exercisable for Company Shares, on
substantially the same terms as the SPAC Warrants and (c) OmnigenicsAI shall enter into an Assignment, Assumption and Amendment Agreement
with the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent, to amend and assume the
Company’s obligations under the existing Warrant Agreement, dated December 6, 2021, to give effect to the conversion of SPAC Warrants
to Company Warrants.

For a full description of the Business Combination
Agreement and the Proposed Business Combination, including additional agreements relating to the Proposed Business Combination, please
see “Item 1. Business”.

Fourth Extension 

On December 8, 2023, we held the December 2023
EGM and our shareholders approved an amendment to its Articles and to the Trust Agreement to provide for the Fourth Extension, which
extends the termination date up to twelve (12) times for an additional one (1) month each time from December 9, 2023 to December 9, 2024
by depositing the lesser of $0.025 per public share or $125,000 for each one-month extension into the Trust Account. In connection with
the December 2023 EGM, the holders of 201,496 public shares properly exercised their right to redeem their shares (and did not withdraw
their redemption) for an aggregate redemption amount of $2,246